C-Path Podcast Highlights Bold Ideas in Drug Development

The Critical Path Institute Podcast started connecting the dots for health innovators around the world one year ago. What started as a bold idea to bring the world of drug development, regulatory science, and clinical research to life through conversation has grown into a rich library of episodes covering everything from clinical outcome assessments and pediatric drug development to rare disease research and the power of data collaboration.

Listen and Learn

Connecting the Dots with COA VP Dr. Cheryl Coon (Inaugural Episode)

CEO Klaus Romero sits down with COA VP Dr. Cheryl Coon to explore how clinical outcome assessments measure what truly matters: how patients feel and function.

Connecting the Dots Between Type 1 Diabetes and Parkinson’s

A surprising and powerful conversation uncovering the fascinating intersections between two seemingly different diseases and what cross-disease collaboration can unlock.

eCOA Conversations with Florence Mowlem, Karl McEvoy, and Brian Lillis

What makes a great eCOA partner? A dynamic panel of industry veterans digs into trust, governance, and the evolving role of technology in clinical trials.

Connecting the Dots with the Data Collaboration Center

Dive into one of C-Path’s most essential teams—the DCC—and discover how data truly powers everything we do.

Connecting the Dots in Quantitative Medicine

A deep dive into the science of modeling and analytics, and how C-Path is using quantitative tools to reshape drug development across multiple disease areas.

Connecting the Dots in Pediatrics

Exploring the unique challenges of drug development for the youngest and most vulnerable patients, and how C-Path is rising to meet them.

eCOA Conversations on Digital Health Technologies

How are digital health technologies transforming the way we collect clinical data? Our eCOA experts have thoughts, and they’re sharing them here.

20 Years of Impact: Reflecting on C-Path’s Legacy and Looking Ahead, Pt. 1

CEO Klaus Romero and President/COO Kristen Swingle mark two decades of C-Path innovation with a look back at our greatest milestones and what they mean for the future of drug development.

20 Years of Innovation: Reflecting on C-Path’s Legacy and Looking Ahead, Pt. 2

The conversation continues! From AI in drug development to decentralized clinical trials and the essential role of patients, this episode is a must-listen for anyone passionate about the future of medicine.

Electronic Clinical Outcome Assessments in Oncology Research

A panel discussion exploring how eCOAs are reshaping data collection and patient experience in oncology research, with real insights from the field.

Connecting the Dots in Rare and Pediatric Diseases

C-Path VP Collin Hovinga joins Klaus Romero to discuss the vast landscape of rare diseases and how C-Path is uniquely positioned to accelerate progress for the communities that need it most.

Connecting the Dots Between T1D and CKD, from the Patient Perspective

Our most recent episode, and one close to our hearts. A candid and inspiring conversation that puts the patient voice front and center in the intersection of type 1 diabetes and chronic kidney disease.

Listen to the full playlist on YouTube.

Posted in AZBio News.